30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Sullivan Lara

Track

Insider profile

Performance

Overall performance
3.1
Performance over holding periods
3.1
30 days 90 days 120 days
Average return 12% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
5 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Sullivan Lara's trades of Pyxis Oncology Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-09-18 2023-09-18
PrS Proposed sale
61,176
447.43
US$1,895,790 		61,176 447.43 US$1,895,790
2023-09-18 2023-09-18
S Sale
52,516 -12.4%
47.66
US$225,318 		52,516 -12.4% 47.66 US$225,318
2023-09-18 2023-09-14
S Sale
32,662 +28.3%
494.73
US$4,492,978 		32,662 +28.3% 494.73 US$4,492,978
2023-09-14 2023-09-14
PrS Proposed sale
100
2.25
US$225 		100 2.25 US$225
2023-09-13 2023-09-13
PrS Proposed sale
3,000
2.27
US$6,816 		3,000 2.27 US$6,816
2023-09-13 2023-09-13
S Sale
3,000 -0.1%
2.27
US$6,816 		3,000 -0.1% 2.27 US$6,816
2023-09-13 2023-09-12
S Sale
4,917 -0.2%
2.25
US$11,071 		4,917 -0.2% 2.25 US$11,071
2023-09-12 2023-09-12
PrS Proposed sale
4,917
2.25
US$11,071 		4,917 2.25 US$11,071
2023-09-13 2023-09-11
S Sale
20,000 -0.8%
2.27
US$45,414 		20,000 -0.8% 2.27 US$45,414
2023-09-11 2023-09-11
PrS Proposed sale
20,000
2.27
US$45,414 		20,000 2.27 US$45,414